623 related articles for article (PubMed ID: 35145413)
1. Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders.
Singh R; Zogg H; Ghoshal UC; Ro S
Front Pharmacol; 2022; 13():808195. PubMed ID: 35145413
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology.
Wei L; Singh R; Ro S; Ghoshal UC
JGH Open; 2021 Sep; 5(9):976-987. PubMed ID: 34584964
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.
Talley NJ; Holtmann G; Walker MM
J Gastroenterol; 2015 Jun; 50(6):601-13. PubMed ID: 25917563
[TBL] [Abstract][Full Text] [Related]
4. Current and Future Approaches for Diagnosing Small Intestinal Dysbiosis in Patients With Symptoms of Functional Dyspepsia.
Shah A; Talley NJ; Holtmann G
Front Neurosci; 2022; 16():830356. PubMed ID: 35600619
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders.
Singh R; Zogg H; Wei L; Bartlett A; Ghoshal UC; Rajender S; Ro S
J Neurogastroenterol Motil; 2021 Jan; 27(1):19-34. PubMed ID: 33166939
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in Disorders of Gut-Brain Interactions: Clinical Insights and Therapeutic Alternatives.
Singh R; Zogg H; Ro S
J Pers Med; 2021 Oct; 11(10):. PubMed ID: 34683162
[TBL] [Abstract][Full Text] [Related]
7. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
Singh P; Lembo A
Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
[TBL] [Abstract][Full Text] [Related]
8. The Gut Microbiome and Colonic Motility Disorders: A Practical Framework for the Gastroenterologist.
Ma W; Drew DA; Staller K
Curr Gastroenterol Rep; 2022 Oct; 24(10):115-126. PubMed ID: 35943661
[TBL] [Abstract][Full Text] [Related]
9. Enterochromaffin Cells-Gut Microbiota Crosstalk: Underpinning the Symptoms, Pathogenesis, and Pharmacotherapy in Disorders of Gut-Brain Interaction.
Wei L; Singh R; Ghoshal UC
J Neurogastroenterol Motil; 2022 Jul; 28(3):357-375. PubMed ID: 35719046
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
Xiao L; Liu Q; Luo M; Xiong L
Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
[TBL] [Abstract][Full Text] [Related]
11. Is there a causal link between psychological disorders and functional gastrointestinal disorders?
Koloski N; Holtmann G; Talley NJ
Expert Rev Gastroenterol Hepatol; 2020 Nov; 14(11):1047-1059. PubMed ID: 32715790
[TBL] [Abstract][Full Text] [Related]
12. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders.
Shin A; Preidis GA; Shulman R; Kashyap PC
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):256-274. PubMed ID: 30153517
[TBL] [Abstract][Full Text] [Related]
13. Recent insights into digestive motility in functional dyspepsia.
Mizuta Y; Shikuwa S; Isomoto H; Mishima R; Akazawa Y; Masuda J; Omagari K; Takeshima F; Kohno S
J Gastroenterol; 2006 Nov; 41(11):1025-40. PubMed ID: 17160514
[TBL] [Abstract][Full Text] [Related]
14. Current and Future Therapeutic Options for Irritable Bowel Syndrome with Diarrhea and Functional Diarrhea.
Piovezani Ramos G; Camilleri M
Dig Dis Sci; 2023 May; 68(5):1677-1690. PubMed ID: 36376576
[TBL] [Abstract][Full Text] [Related]
15. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
Konturek PC; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
[TBL] [Abstract][Full Text] [Related]
16. The role of mast cells in functional GI disorders.
Wouters MM; Vicario M; Santos J
Gut; 2016 Jan; 65(1):155-68. PubMed ID: 26194403
[TBL] [Abstract][Full Text] [Related]
17. The microbiota-gut-brain axis in functional gastrointestinal disorders.
De Palma G; Collins SM; Bercik P
Gut Microbes; 2014; 5(3):419-29. PubMed ID: 24921926
[TBL] [Abstract][Full Text] [Related]
18. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
20. Microbiota modulation in disorders of gut-brain interaction.
Marasco G; Cremon C; Barbaro MR; Bianco F; Stanghellini V; Barbara G
Dig Liver Dis; 2024 May; ():. PubMed ID: 38772789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
